
LaNua Medical
MedTech solutions for embolization, enhancing patient outcomes with targeted therapeutic delivery and adaptable device technology.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | €6.0m | Seed | |
Total Funding | 000k |
Related Content
LaNua Medical operates in the MedTech sector, focusing on developing advanced solutions for embolization procedures. The company is dedicated to creating a device that not only blocks blood flow to specific tissues but also allows for targeted therapeutic delivery, minimizing side effects. This technology is designed to be adaptable for various applications across the human body, addressing multiple disease states such as internal bleeding and tumors. LaNua Medical's business model revolves around providing evidence-based health innovations that improve patient outcomes. The company serves healthcare professionals, particularly interventionalists, by offering them more options to treat their patients effectively. Although the device is still in development and not yet approved for commercial distribution, LaNua Medical is committed to advancing wellness through original thinking and disruptive image-guided technologies. The company's focus on endovascular solutions positions it within a niche market, aiming to address specific medical challenges with its innovative approach. Keywords: MedTech, embolization, patient outcomes, therapeutic delivery, adaptable device, healthcare professionals, endovascular solutions, minimally invasive, disease treatment, wellness advancement.